Gastroesophageal Junction Adenocarcinoma
Showing NaN - NaN of 14
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)
Recruiting
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
- Bemarituzumab
- +3 more
-
Phoenix, Arizona
- +119 more
Feb 1, 2023
Cervical Esophagus Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal
Recruiting
- Cervical Esophagus Adenocarcinoma
- +12 more
- Capecitabine
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)
Not yet recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Fluorouracil
- +4 more
-
Houston, Texas
- +3 more
Nov 13, 2022
Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,
Recruiting
- Solid Tumor
- +7 more
- BNT141
- +2 more
-
Duarte, California
- +10 more
Aug 23, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,
Active, not recruiting
- Gastric Adenocarcinoma
- +2 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 12, 2022
Gastroesophageal Junction Adenocarcinoma, Stage IB Esophageal Adenocarcinoma AJCC v7, Stage II Esophageal Adenocarcinoma AJCC v7
Completed
- Gastroesophageal Junction Adenocarcinoma
- +6 more
- Carboplatin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Feb 16, 2022
Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +12 more
-
Nashville, Tennessee
- +4 more
Feb 3, 2022
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,
Completed
- Metastatic Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Ramucirumab
- +4 more
-
Fayetteville, Arkansas
- +134 more
Jul 29, 2021
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, NSCLC Trial in Worldwide (Ramucirumab, MEDI4736)
Completed
- Gastric Cancer
- +3 more
-
Santa Monica, California
- +27 more
Jan 18, 2021
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab)
Completed
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
-
Tucson, Arizona
- +44 more
Jun 26, 2020
Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III
Unknown status
- Advanced Gastroesophageal Junction Adenocarcinoma
- +24 more
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Jun 18, 2020
Gastroesophageal Junction Adenocarcinoma, Malignant Tumor of the Cervical Esophagus, Malignant Tumor of the Thoracic Esophagus
Completed
- Gastroesophageal Junction Adenocarcinoma
- +7 more
- Carboplatin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 22, 2019
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Georgia, United States
Unknown status
- Gastric Adenocarcinoma
- +2 more
-
Dallas, Texas
- +4 more
Nov 28, 2014